These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 9412611)

  • 1. Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group.
    Grotta J
    Stroke; 1997 Dec; 28(12):2338-46. PubMed ID: 9412611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multinational randomised controlled trial of lubeluzole in acute ischaemic stroke. European and Australian Lubeluzole Ischaemic Stroke Study Group.
    Diener HC
    Cerebrovasc Dis; 1998; 8(3):172-81. PubMed ID: 9619701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Lubeluzole International Study Group.
    Diener HC; Hacke W; Hennerici M; Rådberg J; Hantson L; De Keyser J
    Stroke; 1996 Jan; 27(1):76-81. PubMed ID: 8553408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lubeluzole in acute ischemic stroke treatment: A double-blind study with an 8-hour inclusion window comparing a 10-mg daily dose of lubeluzole with placebo.
    Diener HC; Cortens M; Ford G; Grotta J; Hacke W; Kaste M; Koudstaal PJ; Wessel T
    Stroke; 2000 Nov; 31(11):2543-51. PubMed ID: 11062273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination Therapy Stroke Trial: recombinant tissue-type plasminogen activator with/without lubeluzole.
    Grotta J;
    Cerebrovasc Dis; 2001; 12(3):258-63. PubMed ID: 11641593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular safety of lubeluzole (Prosynap(R)) in patients with ischemic stroke.
    Hacke W; Lees KR; Timmerhuis T; Haan J; Hantson L; Hennerici M; Diener HC
    Cerebrovasc Dis; 1998; 8(5):247-54. PubMed ID: 9712921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acute ischemic stroke with piracetam. Members of the Piracetam in Acute Stroke Study (PASS) Group.
    De Deyn PP; Reuck JD; Deberdt W; Vlietinck R; Orgogozo JM
    Stroke; 1997 Dec; 28(12):2347-52. PubMed ID: 9412612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
    Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
    Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and pharmacokinetics of the neuroprotective drug lubeluzole in patients with ischemic stroke.
    De Keyser J; Van de Velde V; Schellens RL; Hantson L; Tritsmans L; Gheuens J; Van Peer A; Woestenborghs R; Franke CL; van Gorp J
    Clin Ther; 1997; 19(6):1340-51. PubMed ID: 9444444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lubeluzole for acute ischaemic stroke.
    Gandolfo C; Sandercock P; Conti M
    Cochrane Database Syst Rev; 2002; (1):CD001924. PubMed ID: 11869612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remacemide hydrochloride: a double-blind, placebo-controlled, safety and tolerability study in patients with acute ischemic stroke.
    Dyker AG; Lees KR
    Stroke; 1999 Sep; 30(9):1796-801. PubMed ID: 10471426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NXY-059 for acute ischemic stroke.
    Lees KR; Zivin JA; Ashwood T; Davalos A; Davis SM; Diener HC; Grotta J; Lyden P; Shuaib A; Hårdemark HG; Wasiewski WW;
    N Engl J Med; 2006 Feb; 354(6):588-600. PubMed ID: 16467546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischemic stroke.
    Diener HC; Schneider D; Lampl Y; Bornstein NM; Kozak A; Rosenberg G
    Stroke; 2008 Jun; 39(6):1774-8. PubMed ID: 18403736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial.
    Albers GW; Goldstein LB; Hall D; Lesko LM;
    JAMA; 2001 Dec; 286(21):2673-82. PubMed ID: 11730442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lubeluzole. JK 8792, R 87926, Prosynap.
    Drugs R D; 1999 Jan; 1(1):29-31. PubMed ID: 10565978
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial.
    Gharagozli K; Harandi AA; Houshmand S; Akbari N; Muresanu DF; Vester J; Winter S; Moessler H
    J Med Life; 2017; 10(3):153-160. PubMed ID: 29075343
    [No Abstract]   [Full Text] [Related]  

  • 18. Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group.
    Yamaguchi T; Sano K; Takakura K; Saito I; Shinohara Y; Asano T; Yasuhara H
    Stroke; 1998 Jan; 29(1):12-7. PubMed ID: 9445321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervene (Nalmefene) in acute ischemic stroke : final results of a phase III efficacy study. The Cervene Stroke Study Investigators.
    Clark WM; Raps EC; Tong DC; Kelly RE
    Stroke; 2000 Jun; 31(6):1234-9. PubMed ID: 10835438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lubeluzole treatment of acute ischemic stroke.
    Lodder J
    Stroke; 1998 May; 29(5):1067. PubMed ID: 9596259
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.